Schmieg J, Muir J, Aguilera N, Auerbach A
Curr Oncol. 2021; 28(6):5124-5147.
PMID: 34940069
PMC: 8700451.
DOI: 10.3390/curroncol28060430.
Shi X, Ba R, You H, Jiang Q, Huang J, Mao J
Front Med. 2017; 12(3):324-329.
PMID: 29075958
DOI: 10.1007/s11684-017-0558-z.
Weledji E, Enow Orock G
Oncol Rev. 2016; 9(1):274.
PMID: 26779310
PMC: 4698592.
DOI: 10.4081/oncol.2015.274.
Arcaini L, Merli M, Volpetti S, Rattotti S, Gotti M, Zaja F
Clin Dev Immunol. 2012; 2012:638185.
PMID: 22956970
PMC: 3432550.
DOI: 10.1155/2012/638185.
Kimura Y, Sato K, Imamura Y, Arakawa F, Kiyasu J, Takeuchi M
Cancer Sci. 2011; 102(9):1734-41.
PMID: 21609366
PMC: 11158089.
DOI: 10.1111/j.1349-7006.2011.01988.x.
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.
Brown J, Friedberg J, Feng Y, Scofield S, Phillips K, Dal Cin P
Br J Haematol. 2009; 145(6):741-8.
PMID: 19344412
PMC: 2752822.
DOI: 10.1111/j.1365-2141.2009.07677.x.
Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes.
Troussard X, Cornet E
Curr Treat Options Oncol. 2007; 8(2):97-108.
PMID: 17634839
DOI: 10.1007/s11864-007-0015-3.
Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations.
Tierens A, Delabie J, Malecka A, Wang J, Gruszka-Westwood A, Catovsky D
Am J Pathol. 2003; 162(2):681-9.
PMID: 12547726
PMC: 1851160.
DOI: 10.1016/S0002-9440(10)63862-X.
Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas.
Remstein E, James C, Kurtin P
Am J Pathol. 2000; 156(4):1183-8.
PMID: 10751343
PMC: 1876902.
DOI: 10.1016/S0002-9440(10)64988-7.
Low-grade lymphomas: new entities and treatment concepts.
Hagemeister F
Med Oncol. 1995; 12(3):131-42.
PMID: 8852395
DOI: 10.1007/BF01571190.
Primary splenic lymphoma with filiform ultrastructure.
Suresh U, Eyden B, Banerjee S, Reeve N
J Clin Pathol. 1993; 46(6):570-2.
PMID: 8331186
PMC: 501301.
DOI: 10.1136/jcp.46.6.570.
Splenic lymphoma with circulating villous lymphocytes and huge pseudocyst of the spleen.
colovic M, Jankovic G, Perisic-Savic M, colovic R
J R Soc Med. 1993; 86(6):361.
PMID: 8315637
PMC: 1294493.
DOI: 10.1177/014107689308600620.
Splenic lymphoma with circulating villous lymphocytes.
Imbing Jr F, Kumar D, Kumar S, Yuoh G, Gardner F
J Clin Pathol. 1995; 48(6):584-7.
PMID: 7665709
PMC: 502697.
DOI: 10.1136/jcp.48.6.584.
The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement.
Melo J, Foroni L, Brito-Babapulle V, Luzzatto L, Catovsky D
Clin Exp Immunol. 1988; 73(1):23-8.
PMID: 3262465
PMC: 1541467.
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
Bennett J, Catovsky D, Daniel M, Flandrin G, GALTON D, Gralnick H
J Clin Pathol. 1989; 42(6):567-84.
PMID: 2738163
PMC: 1141984.
DOI: 10.1136/jcp.42.6.567.
Tartrate resistant acid phosphatase positive splenic lymphoma: a relatively benign condition occurring in a time-space cluster?.
Kettle P, Morris T, Markey G, Alexander H, CURRY R, Hayes D
J Clin Pathol. 1990; 43(9):714-8.
PMID: 1698823
PMC: 502747.
DOI: 10.1136/jcp.43.9.714.
Clumping of lymphoma cells in peripheral blood induced by EDTA.
Juneja S, Wolf M, McLennan R
J Clin Pathol. 1992; 45(6):538-40.
PMID: 1624607
PMC: 495235.
DOI: 10.1136/jcp.45.6.538.
Splenic lymphoma with villous lymphocytes in two sisters.
Ribeiro I, Costa M, Fernandes B, Sousa I, Melo A, Parreira A
J Clin Pathol. 1992; 45(12):1111-3.
PMID: 1479039
PMC: 495008.
DOI: 10.1136/jcp.45.12.1111.
Cell sizing in chronic lymphoproliferative disorders: an aid to differential diagnosis.
Alexander H, Markey G, Nolan R, Morris T
J Clin Pathol. 1992; 45(10):875-9.
PMID: 1430257
PMC: 495057.
DOI: 10.1136/jcp.45.10.875.